LitAlert ~~ GeneLit.com

    • Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies.
    • Stubbins RJ, Korotev S, Godley LA.
    • Curr Hematol Malig Rep. 2022 Jun 8. doi: 10.1007/s11899-022-00663-7. Epub ahead of print.
    • Review
    • A Turn Off Fluorescence Probe Based on Carbon Dots for Highly Sensitive Detection of BRCA1 Gene in Real Samples and Cellular Imaging.
    • Pirsaheb M, Mohammadi S, Khodarahmi R, Hoseinkhani Z, Mansouri K, Payandeh M.
    • J Fluoresc. 2022 Jun 8. doi: 10.1007/s10895-022-02954-x. Epub ahead of print.
    • African American Prostate Cancer Patients Get More VUS, Fewer Actionable Results, Studies Show.
    • Anderson A.
    • GenomeWeb. Disease Areas. Cancer. 2022 Jun 7.
    • Development, Implementation and Initial Results of CDSS Recommendations for Patients at Risk of Hereditary Breast Cancer.
    • Rosa J, Tajerian M, Zin Y, Brunner M, Lopez N, Gaiera A, Butti M, Menazzi S, Chanfreau H, Luna D, Rubin L, Benitez S.
    • Stud Health Technol Inform. 2022 Jun 6;290:340-344. doi: 10.3233/SHTI220092.
    • Pamiparib for germline BRCA mutation-associated recurrent advanced ovarian, fallopian tube or primary peritoneal cancer.
    • Skrzypczyk-Ostaszewicz A.
    • Drugs Today (Barc). 2022 Jun;58(6):299-309. doi: 10.1358/dot.2022.58.6.3389001.
    • Review
    • Current Systemic Treatments for the Hereditary Cancer Syndromes: Drug Development in Light of Genomic Defects.
    • Hasanov E, Pimentel I, Cruellas M, Lewis MA, Jonasch E, Balmaña J.
    • Am Soc Clin Oncol Educ Book. 2022 Apr;42:1-17. doi: 10.1200/EDBK_350232.